Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
INTRODUCTION: Peroxisome proliferator-activated receptors (PPARs) are the molecular targets of hypolipidemic and insulin-sensitizing drugs and implicated in a multitude of processes that fine-tune the functions of all organs in vertebrates. As transcription factors they sense endogenous and exogenou...
Saved in:
Main Authors: | Tan, Chek Kun, Zhuang, Yan, Wahli, Walter |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/83609 http://hdl.handle.net/10220/42711 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease
by: Fougerat, Anne, et al.
Published: (2020) -
Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology
by: Manickam, Ravikumar, et al.
Published: (2017) -
Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
by: Tan, Nguan Soon, et al.
Published: (2017) -
An aPPARent functional consequence in skeletal muscle physiology via peroxisome proliferator-activated receptors
by: Liao, Zehuan, et al.
Published: (2018) -
Single gene contributions: Genetic variants of peroxisome proliferator-activated receptor (isoforms α, β/δ and γ) and mechanisms of dyslipidemias
by: Yong, E.L., et al.
Published: (2011)